Evidence map›Paper›PMID 39768385›Full record

ArticleLife (Basel, Switzerland)2024

Efficacy of Fractional CO

Ana Gil-Villalba, Ángela Ayén-Rodríguez, María José Naranjo-Díaz, Laura Linares-González, Ricardo Ruiz-Villaverde

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Retrospective Study on COThe journal of obstetrics and gynaecology research · 2025
    Article
  2. Energies and new technologies in pelvic and pelvic floor dysfunctions.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana Gil-VillalbaDermatology Department, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.
Ángela Ayén-RodríguezInstituto Biosanitario de Granada, Ibs, 18012 Granada, Spain.
María José Naranjo-DíazInstituto Biosanitario de Granada, Ibs, 18012 Granada, Spain.
Laura Linares-GonzálezInstituto Biosanitario de Granada, Ibs, 18012 Granada, Spain.
Ricardo Ruiz-VillaverdeInstituto Biosanitario de Granada, Ibs, 18012 Granada, Spain.ORCID 0000-0002-0381-6174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lichen sclerosus (LS) is a chronic inflammatory condition predominantly affecting the anogenital region of postmenopausal women. It is associated with considerable aesthetic and functional impairments and an increased risk of squamous cell carcinoma. While high-potency topical corticosteroids remain the cornerstone of treatment, therapeutic options for patients with refractory LS are scarce. Fractional CO

Indexed as

carbon dioxide laserdyspareunialaser therapylichen sclerosussexual function

Identifiers

PMID39768385
PMCPMC11728231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.